Close

Publication Of Human Genome Sequence Launches New Era In Medicine

Feb 12 2001
WASHINGTON, D.C. (February 12, 2001) - Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement on announcements today that Science and Nature...

BIO Urges Bush To Continue Moratorium On Cloning Human Beings

Feb 1 2001
WASHINGTON, D.C. (February 1, 2001) – Following recent announcements by certain groups of plans to clone human beings, the Biotechnology Industry Organization (BIO) today sent a letter to President...

BIO Letter on Cloning to President Bush

Feb 1 2001
The Honorable George W. BushPresident of the United StatesThe White House1600 Pennsylvania Avenue, NWWashington, DC 20500

Dear Mr. President:

Recently certain groups have...

BIO Says Bush Proposal On Medicare Drug Plan Moves Debate In Positive Direction

Jan 30 2001
WASHINGTON, DC (January 30, 2001) –Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement on President George W. Bush’s Immediate Helping Hand...

BIO’s CEO & Investor Conference Features Companies Leading Industry’s Financial Surge On Wall Street

Jan 25 2001
WASHINGTON, D.C. (January 25, 2001) – The BiotechnologyIndustry Organization’s (BIO) CEO & Investor Conference next month in New York will showcase the companies whose technological and biomedical...

BIO Supportive of FDA Announcement on Biotech Foods

Jan 17 2001
(Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement today regarding a notice of an FDA proposed rule published in today’s Federal Register....

BIO Raises Concerns About FDA’s Proposed Rule On Disclosure Of Gene Therapy Trial Data

Jan 17 2001
WASHINGTON, D.C. (January 17, 2001) -- Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO) issued the following statement on the U.S. Food and Drug Administration’s (FDA)...

BIO names Sharon L. Cohen, senior health policy strategist, as new Vice-President

Jan 9 2001
BIO seeks strong role in Medicare debate

WASHINGTON, D.C. (January 9, 2001) – The Biotechnology Industry Organization (BIO) today named Sharon L. Cohen BIO’s first vice president for...

BIO Issues Statement On PTO’s Final Gene-Based Patent Guidelines

Jan 5 2001
WASHINGTON, D.C. (January 5, 2001) - Lila Feisee, director of intellectual property for the Biotechnology Industry Organization (BIO), issued the following statement on the U.S. Patent and...

CEO & Investor Conference Expected to Attract 1,500 Biotech Leaders and Investors

Dec 22 2000
WASHINGTON, D.C. (December 22, 2000) - The Biotechnology Industry Organization (BIO) will host the third annual CEO & Investor Conference, "Investing in Biotechnology: The Value, The Risks,...